Table.
Characteristics of participants at baseline
| Participant | Age, years | Sex | Number of affected joints | Severity score* | WBC, × 109/L | ESR, mm/h† | CRP, mg/L† | Haptoglobin, g/L† | SAA, mg/L |
|---|---|---|---|---|---|---|---|---|---|
|
FCAS
| |||||||||
| 1 | 74 | F | 4 | 7·5 | 8·8 | 25 | 37 | 1·99 | 293 |
| 2 | 72 | M | 2 | 5 | 9·9 | 18 | 9 | 1·58 | 59 |
| 3 | 55 | F | 4 | 6 | 8·5 | 30 | 16 | 2·30 | 98 |
| 4 | 49 | F | 2 | 8 | 4·2 | 20 | 18 | 1·44 | 57 |
|
| |||||||||
|
Control
| |||||||||
| 5 | 74 | M | 0 | 0 | 5·9 | 2 | <5 | 0·78 | 20 |
| 6 | 54 | M | 0 | 0 | 5·2 | 15 | 22‡ | 1·68 | 79 |
| 7 | 49 | M | 0 | 0 | 6·2 | 34 | 35‡ | 2·56 | 63 |
WBC=white-blood-cell count; ESR=erythrocyte sedimentation rate; CRP=C-reactive protein; SAA=serum amyloid A.
*
Based on self-reported analogue scale (1–10).
†
Normal range: ESR 0–30 mm/h, CRP 0–10 mg/L, haptoglobin 0·16–2·00 g/L.
‡
No history of inflammatory disease, but both controls were slightly obese.